Methods: Data were collected from a multi-professional sample of HCW (N=3275) at a tertiary-care hospital in Ontario, Canada using a cross-sectional survey study. Key motivators and barriers guiding HCW influenza vaccination behaviour were identified through content analysis of HCW reported and ranked qualitative reasons for 1) pH1N1 vaccine uptake or avoidance, and 2) sINFLU vaccine uptake or avoidance.
Results: Most HCW motivators and barriers were similar for both sINFLU and pH1N1 vaccination uptake. Personal motivators (i.e., protection of one’s own health) had the greatest impact on vaccination uptake. Additional motivators included: (1) preventing influenza in family members, colleagues, patients, and their communities, and (2) awareness of HCW role in infection transmission. In contrast, vaccine safety concerns and limited HCW knowledge of influenza vaccines had the greatest impact on non-vaccination. In pandemic settings, HCW were motivated by fear of pH1N1 and workplace pro-vaccination policies. Perceptions of accelerated vaccine development, compromised vaccine safety, conflicting messages about the severity of the pandemic, and distrust/suspiciousness of media, pharmaceutical and regulatory sectors were barriers specific to pH1N1 vaccination uptake.
Conclusion: HCW influenza vaccination may be improved when vaccination campaigns (1) highlight personal benefits of vaccination, (2) emphasize the impact of HCW non-vaccination on others, and (3) include workplace pro-vaccination policies. Furthermore, future communication strategies should ensure consistent messaging about influenza and vaccination safety, especially during pandemics when the virus and the vaccine are perceived to be novel and different from seasonal influenza. The incorporation of these recommendations into vaccination campaigns may help HCW influenza vaccination rates reach recommended targets.
A. Mccarthy, None
R. C. Nair, None
V. Roth, None
K. N. Suh, None
G. Garber, None